It is well known that the MDM2 performs its oncogenic effects through p53-dependent and p53-independen ways, which controls the cell cycle, contributes to the genomic integrity of different cancer cells, and influences the response to numerous DNA damage [45–47]. Here, TP53 is linked to cancer.